Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2861
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00739960 | Safety Study of Abatacept to Treat Refractory Sarcoidosis | ||
| NCT05498480 | Study of Relatlimab in Combination With Nivolumab in Chinese Participants | ||
| NCT03411850 | Sjogrens Syndrome Measured by Ultrasound | ||
| NCT04794010 | A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer | ||
| NCT00213746 | Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study) | ||
| NCT02564497 | A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C | ||
| NCT00534313 | Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis | ||
| NCT00904059 | Drug-Drug Interaction Study in Healthy Subjects | ||
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | ||
| NCT00803374 | Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma | ||
| NCT06215118 | A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) | ||
| NCT01170962 | Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment | ||
| NCT05324436 | A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) | ||
| NCT05524857 | Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) | ||
| NCT02970981 | Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma | ||
| NCT02613507 | Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer | ||
| NCT00935506 | Ex Vivo Human Thrombosis Chamber Study | ||
| NCT06851065 | A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States | ||
| NCT01124344 | Safety and Pharmacology Study of BMS-866949 | ||
| NCT01379287 | Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors | ||
| NCT03245021 | Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A | ||
| NCT00570752 | Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis | ||
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | ||
| NCT04161781 | A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer | ||
| NCT04080804 | Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer | ||
| NCT00004584 | Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment | ||
| NCT00005792 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | ||
| NCT04448964 | A Study of JNJ-70033093 in Healthy Participants | ||
| NCT05420909 | A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC) | ||
| NCT05168436 | A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal | ||
| NCT07221149 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) | ||
| NCT01766050 | Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers | ||
| NCT03563950 | An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants | ||
| NCT01763190 | Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment | ||
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | ||
| NCT00384618 | Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study | ||
| NCT02034578 | Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects | ||
| NCT00207025 | A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies | ||
| NCT03712540 | An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants | ||
| NCT01986218 | Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors | ||
| NCT03445533 | A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma | ||
| NCT00332748 | A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer | ||
| NCT04810078 | A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread | ||
| NCT04624178 | A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma | ||
| NCT07169708 | A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL) | ||
| NCT03335540 | An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment | ||
| NCT07291076 | A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) | ||
| NCT03350126 | iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab | ||
| NCT01333878 | Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage | ||
| NCT00924898 | Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) |
